LUIS CARLOS
JIMÉNEZ ROMERO
Catedrático de universidad
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (16)
2022
-
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Transplantation, Vol. 106, Núm. 7, pp. 1430-1439
-
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342
2020
-
Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients
Nefrologia, Vol. 40, Núm. 3, pp. 265-271
2019
-
A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain
Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567
-
Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study
Transplantation Direct, Vol. 5, Núm. 12
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)
Nefrologia, Vol. 36, Núm. 3, pp. 255-267
2015
-
Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus
Transplantation Direct, Vol. 1, Núm. 7, pp. E24
-
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Liver Transplantation, Vol. 21, Núm. 8, pp. 1056-1065
-
V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante
Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637
2013
-
High incidence of delayed graft function in HIV-infected kidney transplant recipients
Transplant International, Vol. 26, Núm. 9, pp. 893-902
2012
-
Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: The AnemiaTrans study
Advances in Therapy, Vol. 29, Núm. 11, pp. 979-991
2011
-
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients
American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32
2007
-
Gastrointestinal Complications in Renal Transplant Recipients: MITOS Study
Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2190-2193